Loading...

Surveillance of Adverse Events After the First Trivalent Inactivated Influenza Vaccine Produced in Mammalian Cell Culture (Flucelvax®) Reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015

BACKGROUND: In November 2012, the first cell cultured influenza vaccine, a trivalent subunit inactivated influenza vaccine (Flucelvax®, ccIIV3), was approved in the US for adults aged ≥18 years. OBJECTIVE: To assess adverse events (AEs) after ccIIV3 reported to the US Vaccine Adverse Event Reporting...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Vaccine
Main Authors: Moro, Pedro L., Winiecki, Scott, Lewis, Paige, Shimabukuro, Tom T., Cano, Maria
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500456/
https://ncbi.nlm.nih.gov/pubmed/26518405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.10.084
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!